|
1
|
Han SJ, Zhang SW, Chen WQ and Li CL:
Analysis of the status and trends of bladder cancer incidence in
China. Oncology Progress. 11:89–95. 2013.
|
|
2
|
Eapen L: A review of the 2014 English
Language publications pertinent to the treatment of invasive
bladder cancer by radiotherapy. Curr Opin Support Palliat Care.
9:245–248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
James ND, Hussain SA, Hall E, Jenkins P,
Tremlett J, Rawlings C, Crundwell M, Sizer B, Sreenivasan T,
Hendron C, et al: Radiotherapy with or without chemotherapy in
muscle-invasive bladder cancer. N Engl J Med. 366:1477–1488. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zehnder P, Studer UE, Skinner EC, Dorin
RP, Cai J, Roth B, Miranda G, Birkhäuser F, Stein J, Burkhard FC,
et al: Super extended versus extended pelvic lymph node dissection
in patients undergoing radical cystectomy for bladder cancer: A
comparative study. J Urol. 186:1261–1268. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kotwal S, Choudhury A, Johnston C, Paul
AB, Whelan P and Kiltie AE: Similar treatment outcomes for radical
cystectomy and radical radiotherapy in invasive bladder cancer
treated at a united kingdom specialist treatment center. Int J
Radiat Oncol Biol Phys. 70:456–463. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen H, Pong R, Wang Z and Hsieh JT:
Differential regulation of the human gene DAB2IP in normal and
malignant prostatic epithelia: Cloning and characterization.
Genomics. 79:573–581. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shen YJ, Kong ZL, Wan FN, Wang HK, Bian
XJ, Gan HL, Wang CF and Ye DW: Downregulation of DAB2IP results in
cell proliferation and invasion and contributes to unfavorable
outcomes in bladder cancer. Cancer Sci. 105:704–712. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang T, Shen Y, Chen Y, Hsieh JT and Kong
Z: The ATM inhibitor KU55933 sensitizes radioresistant bladder
cancer cells with DAB2IP gene defect. Int J Radiat Biol.
91:368–378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu K, Wang B, Chen Y, Zhou J, Huang J, Hui
K, Zeng J, Zhu J, Zhang K, Li L, et al: DAB2IP regulates the
chemoresistance to pirarubicin and tumor recurrence of non-muscle
invasive bladder cancer through STAT3/Twist1/P-glycoprotein
signaling. Cell Signal. 27:2515–2523. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guleria A and Chandna S: ATM kinase: Much
more than a DNA damage responsive protein. DNA Repair (Amst).
39:1–20. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong Z, Xie D, Boike T, Raghavan P, Burma
S, Chen DJ, Habib AA, Chakraborty A, Hsieh JT and Saha D:
Downregulation of Human DAB2IP gene expression in prostate cancer
cells results in resistance to ionizing radiation. Cancer Res.
70:2829–2839. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Otterson MF, Nie L, Schmidt JL, Link BJ,
Jovanovic N, Lyros O and Rafiee P: EUK-207 protects human
intestinal microvascular endothelial cells (HIMEC) against
irradiation-induced apoptosis through the Bcl2 pathway. Life Sci.
91:771–782. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shrivastav M, Miller CA, de Haro LP,
Durant ST, Chen BP, Chen DJ and Nickoloff JA: DNA-PKcs and ATM
co-regulate DNA double-strand break repair. DNA Repair (Amst).
8:920–929. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Juvekar A, Burga LN, Hu H, Lunsford EP,
Ibrahim YH, Balmañà J, Rajendran A, Papa A, Spencer K, Lyssiotis
CA, et al: Combining a PI3K inhibitor with a PARP inhibitor
provides an effective therapy for BRCA1-related breast cancer.
Cancer Discov. 2:1048–1063. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dent P, Yacoub A, Contessa J, Caron R,
Amorino G, Valerie K, Hagan MP, Grant S and Schmidt-Ullrich R:
Stress and radiation-induced activation of multiple intracellular
signaling pathways. Radiat Res. 159:283–300. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bai M, Ma X, Li X, Mei Q, Li X, Wu Z and
Han W: The Accomplices of NF-κB Lead to Radioresistance. Curr
Protein Pept Sci. 16:279–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hadian K and Krappmann D: Signals from the
nucleus: Activation of NF-kappaB by cytosolic ATM in the DNA damage
response. Sci Signal. 4:pe22011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Di Minin G, Bellazzo A, Dal Ferro M,
Chiaruttini G, Nuzzo S, Bicciato S, Piazza S, Rami D, Bulla R,
Sommaggio R, et al: Mutant p53 reprograms TNF signaling in cancer
cells through interaction with the tumor suppressor DAB2IP. Mol
Cell. 56:617–629. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu HB, Yang K, Xie YQ, Lin YW, Mao QQ and
Xie LP: Silencing of mutant p53 by siRNA induces cell cycle arrest
and apoptosis in human bladder cancer cells. World J Surg Oncol.
11:222013. View Article : Google Scholar : PubMed/NCBI
|
